[ET Net News Agency, 22 April 2024] EVEREST MED-B (01952) rose 10% to HK$23.7, breaking
above the 50-D SMA of HK$22.797.
It hits an intra-day high of HK$23.75, and an intra-day low of HK$21.4. The total shares
traded was 3.34 million, with a value of HK$76.18m. The active buy/sell ratio is 65:35,
with net buying turnover of HK$21.41m. J.P. MORGAN BRO (HK) accounts for greatest net
responsive buying turnover of HK$1.72m, with volume weighted average price of HK$22.917.
CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of
HK$7.78m, with volume weighted average price of HK$22.807.
Basic Information
=================
---------------------------------
Nominal 23.700 % Chg +9.98%
High 23.750 Low 21.400
Shares Tr 3.34m Turnover 76.18m
10-D SMA 24.120 %H.V 79.751
20-D SMA 23.590 VWAP 22.825
50-D SMA 22.797 RSI14 50.209
---------------------------------
Status: Breaking above the 50-D SMA, active buy/sell ratio is 65:35, with net buying
turnover of HK$21.41m
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
EVEREST MED-B (01952) 23.70 +9.98
GENSCRIPT BIO (01548) 11.06 +5.94
INNOVENT BIO (01801) 34.30 +3.31
WUXI BIO (02269) 12.86 +1.90
WUXI APPTEC (02359) 33.60 +1.97
BEIGENE (06160) 80.05 +3.96
CANSINOBIO (06185) 17.68 +7.15
ASCENTAGE-B (06855) 16.74 +6.62
ZAI LAB (09688) 11.48 +6.49
AKESO (09926) 44.70 +1.82
---------------------------------------------
(ed)